Lorenzen, S., Knorrenschild, J. R., Pauligk, C., Hegewisch‐Becker, S., Seraphin, J., Thuss‐Patience, P., Kopp, H., Dechow, T., Vogel, A., Luley, K. B., Pink, D., Stahl, M., Kullmann, F., Hebart, H., Siveke, J., Egger, M., Homann, N., Probst, S., Goetze, T. O., & Al‐Batran, S. (2020). phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC). International journal of cancer, 147(9), 2493–2502. http://access.bl.uk/ark:/81055/vdc_100110803989.0x00005d